Concepedia

Whole-Body Biodistribution and Radiation Dosimetry of <sup>18</sup>F-GE067: A Radioligand for In Vivo Brain Amyloid Imaging

Michel Koole, Dewi M. Lewis, Christopher Buckley, Natalie Nelissen, Mathieu Vandenbulcke, David J. Brooks, Rik Vandenberghe, Koen Van Laere

Journal of Nuclear Medicine · 2009 · 208 citations · 15 references

DOIFull text

Open access

Abstract

The estimated effective dose of (18)F-GE067 for PET amyloid imaging was acceptable (class II-b defined by the World Health Organization), and relatively low variability between subjects was observed.

References

15

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

William E. Klunk, Henry Engler, Agneta Nordberg et al. · Annals of Neurology · 2004 · 4.4K citations

, , +17

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

Miloš D. Ikonomović, William E. Klunk, Eric E. Abrahamson et al. · Brain · 2008 · 921 citations · Full text

PET of Brain Amyloid and Tau in Mild Cognitive Impairment

Gary W. Small, Vladimir Kepe, Linda M. Ercoli et al. · New England Journal of Medicine · 2006 · 732 citations

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

Christopher C. Rowe, Uwe Ackerman, William F. Browne et al. · The Lancet Neurology · 2008 · 664 citations

, , +10

In-Vivo Imaging of Alzheimer Disease  -Amyloid With [11C]SB-13 PET

N. P. L. G. Verhoeff · American Journal of Geriatric Psychiatry · 2004 · 316 citations

, , +8